Delving Into Borderline Personality Disorder Clinical Trial Experiences

Condition(s) studied

Study summary

Taking part in medical study usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical research experience of borderline personality disorder patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future borderline personality disorder patients.

Eligibility

Primary outcome measure(s)

• Number of patients who decide to enroll in a borderline personality disorder clinical research — 3 months
• Rate of patients who remain in borderline personality disorder clinical research to trial completion — 12 months

Trial sites (1)

More Power Life Sciences Inc. trials in the USA